The Value of a Restoration Team with Healthcare Experience

 

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness across healthcare facilities.

He emphasizes the shift from reactive response—so familiar from his firefighting days—to proactive planning in healthcare. “We want to be ahead of the game,” Jason explains, describing how annual preparedness lunches with BMS CAT ensure contact lists, rapid‐response kits, and protocols are current before disasters strike.

A standout story recalls a Christmas Day flood when a vandal snapped a water dispenser off the wall, inundating the basement. Thanks to pre‐established relationships and rapid mobilization, BMS CAT arrived within hours, contained the water, installed temporary walls, and delivered a turnkey restoration—returning the facility to “like it never happened” in just weeks.

Jason also highlights infection control concerns—mold, smoke, odors—and how BMS CAT’s expertise and documentation rigor keep clinical spaces safe and compliant. He praises their ability to offer both emergency manpower and small‐scale remediation training for his in‐house team.

Watch More Episodes From This Series!

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…